Endocyte to Begin Trial of Prostate Cancer Treatment

Posted: Updated:
(Image courtesy of Endocyte) (Image courtesy of Endocyte)

West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is moving forward with its recently-acquired late-stage prostate cancer therapy. The company says it will soon begin a phase 3 trial for PSMA-617, which it says could potentially lead to an early approval of the treatment.

Endocyte says the phase 3 VISION trial for PSMA-617 will include two interim assessments of efficacy. The company expects to begin enrollment in the trial in the second quarter and begin the first interim assessment in the second half of 2019.

Endoycte acquired the therapy in a $12 million deal with Germany-based ABX GmbH last October. At that time, the company said it hoped to complete the trial stages for PSMA-617 as early as 2020.

"Following a successful End of Phase 2 meeting with the FDA, we are excited to launch the VISION trial, a phase 3 registration trial of PSMA-617 in patients with prostate cancer,” said Mike Sherman, chief executive officer of Endocyte. "After extensive collaboration with prostate cancer specialists around the world, the robust and sophisticated VISION trial design will be attractive to patients and physicians when we begin enrollment in the second quarter of 2018. We expect 2018 to be a critical year of execution for us, as we will not only initiate VISION, but also bring our adaptor-controlled chimeric antigen receptor t-cell (CAR T-cell) program into the clinic in the fourth quarter of 2018."

The company is also reporting a full-year net loss of $55.1 million in 2017, compared to a net loss of $43.9 million the previous year. However, the company's net loss for the fourth quarter narrowed to $8.6 million, compared to $11.1 million during the same quarter in 2016.

  • Perspectives

    • Employers Are Key to Improving Healthcare

      It's no longer news that American healthcare is broken. In the U.S., we spend more than $3 trillion a year on healthcare - more than any other developed nation - yet we are in overall poorer health than similarly developed countries. But dealing with healthcare's myriad issues isn't the only challenge facing business owners and employers. They're also grappling with how to attract and retain a shrinking supply of employees.



Company Name:
Confirm Email:
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections


  • Most Popular Stories

    • Angie's List Campus Re-Imagined as Creative 'Playground'

      A group of investors, many with previous ties Angie's List, has closed on the acquisition of the company's former corporate campus. The backers that make up the Fred Abel LLC investment group are led by former Angie's List Chief Executive Officer Bill Oesterle and include participants in Indiana, Massachusetts, North Carolina, New York and Ohio. Boston-based Aquent CEO John Chuang is an investor and says the vision is to "create something far more than office space."

    • (Image courtesy of Indiana Grown)

      Eskenazi, Indiana Grown to Outline Partnership

      Eskenazi Health and Indiana Grown will Monday detail a new partnership at Sidney & Louis Eskenazi Hospital in Indianapolis. The organizations are also hosting a "food networking event" allowing Indiana Grown members to connect with each other and local business owners. Eskenazi Health CEO Dr. Lisa Harris will discuss the partnership this weekend on Inside INdiana Business With Gerry Dick. Indiana Grown, which helps consumers find products grown, raised, produced...

    • $2.5B Coal-to-Diesel Plant Proposed in Dale

      An energy company is proposing a $2.5 billion coal-to-diesel facility in Spencer County. Riverview Energy Corp., which is based in Delaware and has a presence in New York, says the operation would eventually produce 4.8 million barrels of diesel fuel and 2.5 million barrels of naphtha, a liquid used as a solvent, a fuel and in plastics. President Gregory Merle says the facility would be the only one of its kind in the U.S. and is the company's most ambitious project yet.

    • AgriPark, New Jobs in Fishers Future

      The city of Fishers will partner with Brandywine Creek Farms to launch a 30-acre development focused on urban farming. During his State of the City address, Mayor Scott Fadness detailed plans for Fishers AgriPark, which will include crop fields, livestock, aquaponics, beehives and educational space. In today's address, Fadness also said to expect economic development announcements in the coming weeks involving $150 million in capital investment and hundreds of new jobs.

    • On-Air

      Find out when and where you can watch and listen to our reports.